Discovery and Preclinical Evaluation of [4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic Acid, (3S)-3-Morpholinylmethyl Ester (BMS-599626), a Selective and Orally Efficacious Inhibitor of Human Epidermal Growth Factor Receptor 1 and 2 Kinases

被引：28

作者：

Gavai, Ashvinikumar V. ^{[1
]}

Fink, Brian E. ^{[1
]}

Fairfax, David J. ^{[2
]}

Martin, Gregory S. ^{[2
]}

Rossiter, Lana M. ^{[2
]}

Holst, Christian L. ^{[2
]}

Kim, Soong-Hoon ^{[1
]}

Leavitt, Kenneth J. ^{[1
]}

Mastalerz, Harold ^{[1
]}

Han, Wen-Ching ^{[1
]}

Norris, Derek ^{[1
]}

Goyal, Bindu ^{[1
]}

Swaminathan, Shankar ^{[1
]}

Patel, Bharat ^{[1
]}

Mathur, Arvind ^{[1
]}

Vyas, Dolatrai M. ^{[1
]}

Tokarski, John S. ^{[1
]}

Yu, Chiang ^{[1
]}

Oppenheimer, Simone ^{[1
]}

Zhang, Hongjian ^{[1
]}

Marathe, Punit ^{[1
]}

Fargnoli, Joseph ^{[1
]}

Lee, Francis Y. ^{[1
]}

Wong, Tai W. ^{[1
]}

Vite, Gregory D. ^{[1
]}

机构：

[1] Bristol Myers Squibb Res & Dev, Princeton, NJ 08543 USA

[2] Albany Mol Res, Albany, NY 12212 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2009年 / 52卷 / 21期

关键词：

EGFR; HER-2/NEU; DESIGN;

D O I：

10.1021/jm9010065

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Structure-activity relationships in a series of 4-[1H-indazol-5-ylamino]pyrrolo[2,1-f][1,2,4]triazine-6-carbamates identified dual human epidermal growth factor receptor (HER)1/HER2 kinase inhibitors with excellent biochemical potency and kinase selectivity. On the basis of its favorable pharmacokinetic profile and robust in vivo activity in HER1 and HER2 driven tumor models, 13 (BMS-599626) was selected as a clinical candidate for treatment of solid tumors.

引用

页码：6527 / 6530

页数：4

共 50 条

[1] Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-ol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor
Bhide, RS
Cai, ZW
Zhang, YZ
Qian, LG
Wei, D
Barbosa, S
Lombardo, LJ
Borzilleri, RM
Zheng, XP
Wu, LI
Barrish, JC
Kim, SH
Leavitt, K
Mathur, A
Leith, L
Chao, S
Wautlet, B
Mortillo, S
Jeyaseelan, R
Kukral, D
Hunt, JT
Kamath, A
Fura, A
Vyas, V
Marathe, P
D'Arienzo, C
Derbin, G
Fargnoli, J
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (07) : 2143 - 2146
[2] Discovery of brivanib alaninate ((S)-((R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), a novel prodrug of dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinase inhibitor (BMS-540215)
Cai, Zhen-Wei
Zhang, Yongzheng
Borzilleri, Robert M.
Qian, Ligang
Barbosa, Stephanie
Wei, Donna
Zheng, Xiaoping
Wu, Lawrence
Fan, Junying
Shi, Zhongping
Wautlet, Barri S.
Mortillo, Steve
Jeyaseelan, Robert, Sr.
Kukral, Daniel W.
Kamath, Amrita
Marathe, Punit
D'Arienzo, Celia
Derbin, George
Barrish, Joel C.
Robl, Jeffrey A.
Hunt, John T.
Lombardo, Louis J.
Fargnoli, Joseph
Bhide, Rajeev S.
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (06) : 1976 - 1980
[3] Molecular Structure and Supramolecular Architecture of Brivanib: (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f] [1,2,4]triazin-6-yloxy)propan-2-ol
Cai, Jie
Zhang, Ruirui
CRYSTALLOGRAPHY REPORTS, 2022, 67 (07) : 1183 - 1186
[4] Molecular Structure and Supramolecular Architecture of Brivanib: (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f] [1,2,4]triazin-6-yloxy)propan-2-ol
Jie Cai
Ruirui Zhang
Crystallography Reports, 2022, 67 : 1183 - 1186
[5] Development of New N -{4-[(7-Chloro-5-methylpyrrolo[2,1-f ] [1,2,4]triazin-4-yl)oxy]-3-fluorophenyl}benzenesulfonamide Analogues: Exploring Anticancer Potential through MerTK Inhibition
Sathe, Balaji Dashrath
Meenakshi, Meenakshi
Murti, Yogesh
Mane, Madhav Shivaji
Pandey, Sarvesh Kumar
Mahajan, Shriya
Rawat, Pramod
Kandhari, Harsimrat
Goel, Kapil Kumar
Dwivedi, Ashish Ranjan
Rathod, S. V.
SYNLETT, 2024,
[6] Discovery and preclinical studies of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[ 2,3-b] pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo active potent VEGFR-2 inhibitor
Ruel, Rejean
Thibeault, Carl
L'Heureux, Alexandre
Martel, Alain
Cai, Zhen-Wei
Wei, Donna
Qian, Ligang
Barrish, Joel C.
Mathur, Arvind
D'Arienzo, Celia
Hunt, John T.
Kamath, Amrita
Marathe, Punit
Zhang, Yueping
Derbin, George
Wautlet, Barri
Mortillo, Steven
Jeyaseelan, Robert, Sr.
Henley, Benjamin
Tejwani, Ravindra
Bhide, Rajeev S.
Trainor, George L.
Fargnoli, Joseph
Lombardo, Louis J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (09) : 2985 - 2989
[7] Discovery of 2-(4-((1H-1,2,4-triazol-1-yl)methyl)-5-(4-bromophenyl)-1-(2-chlorophenyl)-1H-pyrazol-3-yl)-5-tert-butyl-1,3,4-thiadiazole (GCC2680) as a potent, selective and orally efficacious cannabinoid-1 receptor antagonist
Lee, Jinhwa
Seo, Hee Jeong
Lee, Suk Ho
Kim, Jeongmin
Jung, Myung Eun
Lee, Sung-Han
Song, Kwang-Seop
Lee, Junwon
Kang, Suk Youn
Kim, Min Ju
Kim, Mi-Soon
Son, Eun-Jung
Lee, MinWoo
Han, Ho-Kyun
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (17) : 6377 - 6388
[8] (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1H-1,2,4-triazo1-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950):: A rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitor with reduced myotoxicity potential
Ahmad, Saleem
Madsen, Cort S.
Stein, Philip D.
Janovitz, Evan
Huang, Christine
Ngu, Khehyong
Bisaha, Sharon
Kennedy, Lawrence J.
Chen, Bang-Chi
Zhao, Rulin
Sitkoff, Doree
Monshizadegan, Hossain
Yin, Xiaohong
Ryan, Carol S.
Zhang, Rongan
Giancarli, Mary
Bird, Eileen
Chang, Ming
Chen, Xing
Setters, Robert
Search, Debra
Zhuang, Shaobin
Nguyen-Tran, Van
Cuff, Carolyn A.
Harrity, Thomas
Darienzo, Celia J.
Li, Tong
Reeves, Richard A.
Blanar, Michael A.
Barrish, Joel C.
Zahler, Robert
Robl, Jeffrey A.
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (09) : 2722 - 2733
[9] Discovery of the SHP2 allosteric inhibitor 2-((3R,4R)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-5-(2,3-dichlorophenyl)-3-methylpyrrolo[2,1-f][1,2,4] triazin-4(3H)-one
Luo, Yanmei
Li, Jin
Zong, Yuliang
Sun, Mengxin
Zheng, Wan
Zhu, Jiapeng
Liu, Liu
Liu, Bing
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2023, 38 (01) : 398 - 404
[10] Synthesis and biological evaluation of N-(3-fluorobenzyl)-4-(1-(methyl-d3)-1H-indazol-5-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-amine as a novel, potent ALK5 receptor inhibitor
Kang, Byung-Nam
Kang, Hong-Jun
Kim, Sunjoo
Lee, Jungwoo
Lee, Jinwoo
Jeong, Hee-Jin
Jeon, Seeun
Shin, Youngdo
Yoon, Cheolhwan
Han, Cheolkyu
Seo, Jeongbeob
Yun, Jaesook
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 85

← 1 2 3 4 5 →